Elevated Serum Bisphenol A Levels Are Linked to Intracerebral Hemorrhage Risk in Young Patients
Guoping Wang,Jinhua Chen,Zhongdong Qiao,Lili Zhao,Dongxing Guo,Ping Guo,Yangzhou Wang,Wanli Sun,Lifang Zhang,Jiyuan Lyu
DOI: https://doi.org/10.2139/ssrn.3697987
2020-01-01
Abstract:Background: Bisphenol A (BPA) is a widely used industrial chemical and is associated with many diseases. Here, we investigated the relationship between serum BPA concentration and endocrine function, cytokines, and ambulatory blood pressure indicators in young patients with unexplained intracerebral hemorrhage (YUICH).
Methods: 380 YUICH patients and normal control subjects (n = 380) were recruited from Changzhi People's Hospital affiliated to Shanxi Medical University and Changzhi Heping Hospital affiliated to Changzhi Medical College. The serum BPA, insulin-like growth factor-1 (IGF-1), N-terminal brain natriuretic peptide (NT pro-BNP), matrix metalloproteinase 9 (MMP-9) and TOLL-like receptor 4 ( TLR-4) level. Radioimmunoassay was used to detect the serum levels of S100B protein (S100B), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), total testosterone (TT) and free testosterone (FT). Observe the variability of blood pressure levels through 24-hour ambulatory blood pressure monitoring, and use cerebrovascular computed tomography and magnetic resonance imaging for routine measurement.
Findings: The following parameters of YUICH patients increased significantly compared with the normal control group. Serum BPA (0.85±0.15 vs 0.535±0.11 pg/ml), MMP-9 (104±10 vs 53±8.1 pg/ml), S100B (0.105±0.024 vs. 0.098±0.02μg/L), IL-1β (0.60±0.04 vs. 0.19±0.03 ng/ml), TNFα (1.29±0.13vs0.66±0.09 ng/L), TLR-4 (12.04±1.14vs 5.69±144 ), NT pro-BNP (1464±97 vs. 353), TPO-Ab (81.55±16.7 vs 8.7±2.7 IU/l). The following parameters were significantly reduced compared with the control group, IGF-1 (65.2±10.4 vs 105±9.5 ng/l), P <0.01.The FT4 of male patients with YUICH was higher than that of the control group (45±10.2 vs 26±9.2 nmol/l), and the TSH level of female patients with YUICH was higher than that of the control group (9±2.3 vs 2.1±0.4 ng/l, P<0.01). The serum free testosterone level of male patients with YUICH was lower compared with the control group (0.18±0.03 vs 0.21±0.02 nmol/l). Serum BPA is positively correlated with TPO-Ab, NT-pro BNP, FT4, MMP-9, IL-1β, S100B, and TNF-α (r = 0.47), (r = 0.50), (r = 0.42), (R = 0.43) (r = 0.44), (r = 0.46), both P <0.01 and (r = 0.38, P <0.05); serum BPA is negatively correlated with IGF-1 and free testosterone (r =- 0.49), (r = -0.46), P <0.01; while serum S100B is positively correlated with 24hSBPCV, MMP-9 (r = 0.45), (r = 0.51), MMP-9 is positively correlated with nDBPCV (r = 0.51) TLR -4 is positively correlated with IL-1β (r = 0.52) P<0.01.
Interpretation: Thus, BPA exposure will destroy a variety of hormone systems, and the production of cytokines and the variability of ambulatory blood pressure may be involved in the pathophysiological process and pathogenesis of YUICH.
Trial Registration: Chinese Clinical Trial Registry A Primary Registry of International Clinical Trial Registry Platform, World Health Organization. Clinical trials.gov. Chi CTR1900023626.
Funding Statement: This work was supported by the Natural Science Foundation of Shanxi Province (grant nos. 2010011055-1 and 201701D121177); Shanxi Provincial Science and Technology Department of the Project Fund (grant no. 2011099); and Spark Planning Project of Changzhi City of Shanxin Province (grant no. 200704009).
Declaration of Interests: The authors declare no competing interests.
Ethics Approval Statement: All patients provided written, informed consent prior to participation in the study. The protocol was approved by Changzhi People’s Hospital and the Ethics Committee of Shanxi Medical University Affiliated Hospital (approval no.2013093).confirming that all experiments were performed in accordance with relevant guidelines and regulations.